Abstract:Background The toll-like receptor 4 (TLR4) agonist, Bacille Calmette-Guérin, has exhibited gratifying effects in treating bladder cancer. The study aims to explore the expression pattern, prognostic value, and potential mechanism of TLR4 in bladder cancer. Methods The transcriptome file from the GSE13507 dataset in the Gene Expression Omnibus database and the promoter methylation file from the bladder cancer dataset in The Cancer Genome Atlas database were downloaded for analysis. The prognostic value of the TLRs was assessed by univariate Cox regression. Immunohistochemistry was applied to verify the expression of TLR4 in bladder cancer. The drug response is estimated through the R package “pRRophetic.” The CIBERSORT algorithm was carried out to estimate the infiltrating immune cells of samples. Gene Set Enrichment Analysis (GSEA) was performed to identify the pathways involved under varied TLR4 expression levels. Results TLR4 is decreased in tumor tissues compared with surrounding tumor tissues or normal tissue, which is also positively correlated to the overall survival rate (hazard ratio [HR] = 0.38) and cancer-specific survival rate (HR = 0.15) of patients with bladder cancer. Low expression of TLR4 is observed in tumors with malignant performance (high pathological grade, higher tumor stage, and progression). Patients with low TLR4 levels are more sensitive to gemcitabine rather than cisplatin. The promoter methylation level of TLR4 is positively associated with TLR4 expression ( P < 0.001). The cg14629571 methylation site largely contributes to the overall methylation level. The CIBERSORT analysis shows that high TLR4 expression is associated with lower levels of plasma cells, M0 macrophages, and M1 macrophages. The GSEA results indicate that the TGF-β pathway and apoptosis are activated in high TLR4 bladder cancer, while G2M checkpoint and E2F targets pathways are enriched in low TLR4 bladder cancer. Conclusion This research discusses the abnormal expression and prognostic value of TLR4 in bladder cancer. The TLR4 expression can effectively predict oncological outcomes and drug sensitivity of bladder cancer patients. TLR4 is also associated with infiltrating immune cell variation and cancer pathway dysregulation. The results provide a novel prognostic marker and potential drug targets for bladder cancer.

Expression of DR4,and DR5 in Bladder Cancer:Correlation With Response to Adjuvant Therapy and Implications of Prog-nosis

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expressions of cyclooxygenase-2 and epidermal growth factor receptor in transitional cell carcinoma of bladder and their correlation

EPDR1 levels and tumor budding predict and affect the prognosis of bladder carcinoma

Overexpressions of DLL4 and CD105 Are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

The expression of CXCL5 in bladder cancer and its clinical significance

Death Receptor 4 and Bladder Cancer Risk 1

The Association of Death Receptors and TGF-β1 Expression in Urothelial Bladder Cancer and Their Prognostic Significance

Death Receptor 4 And Bladder Cancer Risk

Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis

Expression of CXCR7 Protein in Human Bladder Cancer and Its Clinical Significance

Expression of Apoptosis Inhibitor Gene Survivin in Bladder Carcinoma and Its Clinical Implication

Expression of Oct4 Protein in Non-Muscle-invasive Bladder Cancer

Expressions Correlation of P53,vegf,cox-2 and EGFR in Bladder Cancer and Their Clinical Significance

Platelet-Derived Endothelial Cell Growth Factor Expression in Tumor and Stroma Cells of Bladder Transitional Cell Carcinoma

High Expression of MDR1 is Correlated with Poor Prognosis for Common Malignancies

Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis

Expression of chemokine CXCL5 and programme death ligand 1 in colorectal cancer tissues are associated with prognosis of patients

Distribution and Clinical Significance of CD4 +CD25 +Treg Cells in Microenvironment of Urothelial Carcinoma of Urinary Bladder

Poliovirus Receptor CD155 is Up-Regulated in Muscle-Invasive Bladder Cancer and Predicts Poor Prognosis.

Expression of CD4~+ CD25~+ regulatory T cells in human bladder carcinoma and its clinical significance